Study Summary
This trial shows that the SpaceOAR system is effective in reducing late GI toxicity in people undergoing SBRT to treat prostate cancer.
- Prostate Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 3 to 24 months post-SBRT initiation
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
No-Spacer Control
1 of 2
SpaceOAR Vue
1 of 2
Active Control
Experimental Treatment
500 Total Participants · 2 Treatment Groups
Primary Treatment: SpaceOAR Vue System · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many medical facilities are conducting this trial?
"Across the United States, 8 medical centres are offering this treatment. Examples include Florida Urology Partners in Tampa, GenesisCare USA in Fort Myers, and Kansas University Medical Center in Troy." - Anonymous Online Contributor
Are there still opportunities for participation in this research project?
"Data hosted on clinicaltrials.gov affirms that this medical experiment, initially posted in December of 2021, is currently recruiting patients. The study has also been updated as recently as November 17th 2022." - Anonymous Online Contributor
What is the population size of participants in this investigation?
"To carry out the study, 500 patients who meet inclusion criteria must be enrolled. Boston Scientific Corporation is responsible for operating the trial through its multiple sites including Florida Urology Partners, LLC in Tampa and GenesisCare USA in Fort Myers." - Anonymous Online Contributor